Evaluation Of Time-To-Recurrence Of Disease Activity In Treatment-Naive Patients With Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment: 12-Month Analysis From The Oracle Study
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2017）
Key words
macular degeneration,ranibizumab treatment-naïve,time-to-recurrence,age-related
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined